We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




MRI Detects Breast Cancer at Earlier Stage

By HospiMedica International staff writers
Posted on 31 Dec 2009
Magnetic resonance imaging (MRI) combined with mammography detects nearly all tumors at an early stage, thereby reducing the incidence of advanced stage breast cancer in high-risk women.

"Earlier stage breast cancers are more likely to be curable,” said lead researcher Ellen Warner, M.D., M.Sc., medical oncologist in the department of medicine, division of medical oncology at Sunnybrook Health Sciences Center (Toronto, Canada; Sunnybrook Health Sciences Center (Toronto, Canada). More...
"We can be fairly confident that if screening with MRI finds cancers at a much earlier stage, it probably also saves lives,” added Dr. Warner, who presented details of these results at the CTRC-AACR San Antonio [TX, USA] Breast Cancer Symposium, held December 9-13, 2009.

The researchers separated 1,275 women at high risk for breast cancer into two groups: One group was screened with MRI scanning plus mammography, and the second, a control group, received conventional screening by mammography. Participants had the defective BRCA1 or BRCA2 gene mutation, which suggests a very high lifetime risk of developing breast cancer.

Dr. Warner and colleagues tracked the women over several years to determine which screening method detected cancer at a considerably earlier stage. Forty-one cases of breast cancer were diagnosed in the MRI group compared with 76 diagnoses in the control group. There were proportionately fewer advanced breast tumors, and more early cancers among women who screened with MRI compared with those not screened with MRI.

Furthermore, cancer size was smaller in the MRI group. The average size of invasive cancers in the MRI group was 0.9 cm compared to 1.8 cm in the control group. Three percent of cancers in the MRI group were larger than 2 cm in diameter compared with 29% of those in the control group.

"These results will hopefully convince high-risk women and their healthcare providers that breast screening with yearly MRI and mammography is a reasonable alternative to surgical removal of their breasts, which is commonly done to prevent breast cancer,” Dr. Warner said.

Related Links:
Sunnybrook Health Sciences Center



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Silver Member
ECG Management System
NEMS Web
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.